Randomly methylated β‐cyclodextrin derivatives enhance taxol permeability through human intestinal epithelial Caco‐2 cell monolayer-Reference-Cited by-同舟云学术

Randomly methylated β‐cyclodextrin derivatives enhance taxol permeability through human intestinal epithelial Caco‐2 cell monolayer

Published:2011-11 Issue:11 Volume:100 Page:4734-4744
ISSN:0022-3549
Container-title:Journal of Pharmaceutical Sciences
language:en
Short-container-title:Journal of Pharmaceutical Sciences

Author:

Fenyvesi Ferenc,Kiss Tímea,Fenyvesi Éva,Szente Lajos,Veszelka Szilvia,Deli Mária A.,Váradi Judit,Fehér Pálma,Ujhelyi Zoltán,Tósaki Árpád,Vecsernyés Miklós,Bácskay Ildikó

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference45 articles.

1. Paclitaxel (Taxol);Rowinsky;New Engl J Med,1995

2. Oral delivery of taxanes;Malingré;Invest New Drugs,2001

3. Bioanalysis, pharmacokinetics, and pharmacodynamics of a novel anticancer drug paclitaxel (Taxol);Beijnen;Semin Oncol,1994

4. Pharmacokinetics of paclitaxel in experimental animals. Part 1. Blood levels;Fujita;Gan To Kagaku Ryoho,1994

5. Taxol: Mechanisms of action and resistance;Horwitz;J Natl Cancer I,1993

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Liquiritin-Hydroxypropyl-Beta-Cyclodextrin Inclusion Complex: Preparation, Characterization, Bioavailability and Antitumor Activity Evaluation;Journal of Pharmaceutical Sciences;2022-07

2. Anti-tumor pharmacology of natural products targeting mitosis;Cancer Biology & Medicine;2022-06-15

3. Cyclodextrins as multitask agents for metal nano-heterogeneous catalysis: a review;Environmental Chemistry Letters;2021-08-24

4. Erlotinib complexation with randomly methylated β-cyclodextrin improves drug solubility, intestinal permeability, and therapeutic efficacy in non-small cell lung cancer;Pharmaceutical Development and Technology;2021-07-05

5. A liposome-micelle-hybrid (LMH) oral delivery system for poorly water-soluble drugs: Enhancing solubilisation and intestinal transport;European Journal of Pharmaceutics and Biopharmaceutics;2020-09